Terms: = Uterine cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Treatment
13 results:
1. The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study.
da Costa LT; Dos Anjos LG; Kagohara LT; Torrezan GT; De Paula CAA; Baracat EC; Carraro DM; Carvalho KC
Clinics (Sao Paulo); 2021; 76():e2324. PubMed ID: 33503190
[TBL] [Abstract] [Full Text] [Related]
2. An organoid-based drug screening identified a menin-mll inhibitor for endometrial cancer through regulating the HIF pathway.
Chen J; Zhao L; Peng H; Dai S; Quan Y; Wang M; Wang J; Bi Z; Zheng Y; Zhou S; Liu Y; Chen C; Na F
Cancer Gene Ther; 2021 Feb; 28(1-2):112-125. PubMed ID: 32632269
[TBL] [Abstract] [Full Text] [Related]
3. [Knockdown of ACSS2 inhibits invasion and migration of cervical cancer cells induced by nutrient stress and its mechanism].
Su Y; Ling R; Zhou Y; Chen D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Oct; 35(10):926-931. PubMed ID: 31814569
[TBL] [Abstract] [Full Text] [Related]
4. Impact of Initiating Screening Programs on Referral and Management of Cervical cancer in Tanzania.
Sedani A; Soliman AS; Msami K; Msemo D; Mwaiselage J; Schmid K; Kahesa C
J Glob Oncol; 2019 Jul; 5():JGO1800052. PubMed ID: 31343933
[TBL] [Abstract] [Full Text] [Related]
5. Rare myeloid sarcoma with kmt2a (mll)-ELL fusion presenting as a vaginal wall mass.
Bao H; Gao J; Chen YH; Altman JK; Frankfurt O; Wilson AL; Sukhanova M; Chen Q; Lu X
Diagn Pathol; 2019 Mar; 14(1):26. PubMed ID: 30922345
[TBL] [Abstract] [Full Text] [Related]
6. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
[TBL] [Abstract] [Full Text] [Related]
7. Computerized tomography-guided percutaneous high-dose-rate interstitial brachytherapy for malignant lung lesions.
Sharma DN; Rath GK; Thulkar S; Bahl A; Pandit S; Julka PK
J Cancer Res Ther; 2011; 7(2):174-9. PubMed ID: 21768706
[TBL] [Abstract] [Full Text] [Related]
8. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering cancer Center.
Abu-Rustum NR; Alektiar K; Iasonos A; Lev G; Sonoda Y; Aghajanian C; Chi DS; Barakat RR
Gynecol Oncol; 2006 Nov; 103(2):714-8. PubMed ID: 16740298
[TBL] [Abstract] [Full Text] [Related]
9. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS;
J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331
[TBL] [Abstract] [Full Text] [Related]
10. Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21; q23): mll rearrangement, p53 mutation and multilineage involvement.
Bigoni R; Cuneo A; Roberti MG; Moretti S; De Angeli C; Dabusti M; Campioni D; del Senno L; Biondi A; Chaplin T; Young BD; Castoldi G
Leukemia; 1999 May; 13(5):704-7. PubMed ID: 10374873
[TBL] [Abstract] [Full Text] [Related]
11. Multimodal treatment for the locally advanced stage IB, IIA, IIB patients of cervical cancer.
Kim SJ
Int J Gynaecol Obstet; 1995 Jul; 49 Suppl():S49-57. PubMed ID: 7589741
[TBL] [Abstract] [Full Text] [Related]
12. Prognosis of endometrial carcinoma stage I in two Swedish regions. A study with special regard to the effects of intracavitary irradiation with high dose-rate afterloading technique or with low dose-rate radium.
Sorbe B; Kjellgren O; Sténson S
Acta Oncol; 1990; 29(1):29-37. PubMed ID: 2310601
[TBL] [Abstract] [Full Text] [Related]
13. [Two-decade record of gynaecological department in municipal hospital of Berlin-Friedrichshain in graduated treatment of carcinoma in situ (author's transl)].
Lunow E; Müller M
Zentralbl Gynakol; 1979; 101(20):1314-22. PubMed ID: 539209
[TBL] [Abstract] [Full Text] [Related]
